Despite modest revenue, Sera Prognostics maintained its focus on building long-term value through Medicaid engagement and strategic expansion. Operating expenses remained flat, and net loss narrowed slightly year-over-year.

In Q2 2025, Sera Prognostics generated $17K in revenue, down from $24K a year earlier. Operating expenses were $9.3M, flat year-over-year, with lower R&D costs offset by higher selling and marketing expenses. The company reported a net loss of $8.0M, or $0.16 per share. Cash, cash equivalents, and available-for-sale securities totaled $108.5M, expected to fund operations through 2028.

Sera Prognostics reported first quarter 2025 revenue of $38,000, up from nil in the prior year. The company's net loss for the quarter was $8.2 million, a slight increase from $8.1 million in the prior-year quarter. Total operating expenses were $9.3 million, compared to $9.1 million in the first quarter of 2024.

Sera Prognostics experienced a decline in revenue for Q4 2024 and continued investments in commercialization and research, resulting in a higher net loss. Despite this, the company raised additional funds to support its operations and future growth.

Sera Prognostics reported third quarter 2024 revenue of $29,000, a decrease from $42,000 in the same period of 2023. The net loss for the quarter was $7.9 million, compared to $7.2 million for the prior-year period.

Sera Prognostics reported a decrease in revenue for the second quarter of 2024, but also saw a reduction in operating expenses and a narrower net loss compared to the same period in the previous year.

Sera Prognostics reported a decrease in revenue due to adjustments related to old accounts, resulting in net revenue of nil for Q1 2024. However, the company reduced operating expenses by 20% and narrowed its net loss by 24%. They are focusing on future revenue growth through data publication, new commercial opportunities, and international market exploration.

Sera Prognostics reported fourth quarter 2023 revenue of $41,000, a decrease compared to $65,000 for the same period in 2022. The net loss for the quarter was $7.9 million, compared to $9.7 million for the same quarter a year ago.

Sera Prognostics reported Q3 2023 revenue of $42,000, a decrease from $87,000 in the same period of 2022. The company's net loss was $7.2 million, an improvement compared to $10.7 million in Q3 2022. Management completed planned cost reduction activities to extend cash runway through most of 2027.

Sera Prognostics reported second quarter 2023 revenue of $123,000, a net loss of $10.5 million, and cash, cash equivalents, and available-for-sale securities of approximately $92.1 million as of June 30, 2023.

Sera Prognostics reported first quarter 2023 revenue of $100,000, compared to $38,000 for the same period in 2022. The net loss for the quarter was $10.6 million, an improvement over the $12.2 million loss in the first quarter of the previous year. The company had $100 million in cash, cash equivalents, and available-for-sale securities as of March 31, 2023.

Sera Prognostics reported fourth quarter 2022 revenue of $65,000, compared to $26,000 for the same period in 2021. The net loss for the fourth quarter of 2022 was $9.7 million, compared to $12.5 million for the same quarter a year ago.

Sera Prognostics reported increased revenue for the third quarter of 2022, reaching $87,000 compared to $23,000 in the same period of 2021. However, the company experienced a net loss of $10.7 million, slightly higher than the $9.9 million loss in the third quarter of the previous year. The company's cash, cash equivalents, and available-for-sale securities totaled approximately $111.2 million as of September 30, 2022.

Sera Prognostics reported a revenue of $78,000 for the second quarter of 2022, compared to $20,000 for the same period in 2021. The company's net loss for the quarter was $11.5 million, and they had approximately $121 million in cash, cash equivalents, and available-for-sale securities as of June 30, 2022.

Sera Prognostics reported first quarter 2022 revenue of $38,000, compared to $13,000 for the same period in 2021. The net loss for the quarter was $12.2 million, compared to $6.4 million for the same quarter a year ago. As of March 31, 2022, the Company had cash and cash equivalents of approximately $64.1 million.

Sera Prognostics reported fourth quarter 2021 revenue of $26,000, compared to $6,000 for the same period in 2020. The net loss for the quarter was $12.5 million, compared to $5.4 million for the same quarter a year ago.

Sera Prognostics reported third quarter 2021 revenue of $23,000, an increase from $5,000 for the same period in 2020. Net loss for the quarter was $9.9 million, compared to $5.1 million for the same quarter a year ago. The company had cash and cash equivalents of approximately $82.5 million and $67.5 million of available-for-sale securities as of September 30, 2021.